EPINEPHRINE
| Brand name | EPINEPHRINE |
|---|---|
| Active ingredient | EPINEPHRINE |
| Strength | 30MG/30ML (1MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| Modality | Small molecule |
| FDA approval | March 2025 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12539283 | January 2045 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.